OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron
José M. Casasnovas, Yago Margolles, María A. Noriega, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications
Ki Sung Park, Tae-In Park, Jae Eon Lee, et al.
Biosensors (2024) Vol. 14, Iss. 3, pp. 146-146
Open Access | Times Cited: 6

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity
Julia Revuelta, Luciana Rusu, Clara Francés‐Gómez, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access

Screening and functional studies of Norrin-related nanobodies
Yiwen Xu, Yiang Wang, Zhongyun Lan, et al.
Protein Expression and Purification (2025), pp. 106717-106717
Closed Access

Small but Mighty: Nanobodies in the Fight Against Infectious Diseases
Wenning Jiang, Chundong Huang, Serge Muyldermans, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 610-610
Open Access

Identification of Significant Mutations in Spike Protein of SARS‐CoV‐2 Variants of Concern and the Discovery of Potent Inhibitors
Mohsen Almakrami, Mohammed Bazuqamah, Mohammed A. Alshehri, et al.
Global Health (2025) Vol. 2025, Iss. 1
Open Access

Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
Hung Van Nguyen, Hoang Linh Nguyen, Pham Dang Lan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 18, pp. 6497-6553
Closed Access | Times Cited: 9

SARS-CoV-2 prevalence in domestic and wildlife animals: A genomic and docking based structural comprehensive review
Tuhin Das, Suranjana Sikdar, Md. Helal Uddin Chowdhury, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19345-e19345
Open Access | Times Cited: 7

SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2–infected individuals interact with Fc receptor–expressing cells but do not neutralize the virus
Daniel Fernández-Soto, Paula Alexandra Reis Bueno, Urtzi Garaigorta, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 5, pp. 985-991
Open Access | Times Cited: 2

Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses
Miguel Rodríguez Pulido, Eva Calvo-Pinilla, Miryam Polo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance
Alejandro Prieto, Lluïsa Miró, Yago Margolles, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 2

Virus–Receptor Interactions and Receptor-Mediated Virus Entry into Host Cells
José M. Casasnovas
Sub-cellular biochemistry/Subcellular biochemistry (2024), pp. 533-566
Closed Access | Times Cited: 2

Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2
Wenyi Wang, Yue Hu, Bohan Li, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115401-115401
Open Access | Times Cited: 10

Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance
Alejandro Prieto, Lluïsa Miró, Yago Margolles, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1

Redirecting a Broad-Spectrum Nanobody Against the Receptor-Binding Domain of SARS-CoV-2 to Target Omicron Variants
Kwanpet Intasurat, Nonth Submunkongtawee, Phoomintara Longsompurana, et al.
Applied Sciences (2024) Vol. 14, Iss. 22, pp. 10548-10548
Open Access | Times Cited: 1

AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity
Pablo Botella-Asunción, Eva Rivero‐Buceta, Carla Vidaurre-Agut, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115882-115882
Open Access | Times Cited: 3

Bridelia ferruginea phytocompounds interact with SARS-COV-2 drug targets: Experimental validation of corilagin contribution
Olaposi Idowu Omotuyi, Babatunji Emmanuel Oyinloye, Samuel Agboola, et al.
Scientific African (2023) Vol. 22, pp. e01920-e01920
Open Access | Times Cited: 2

Combination Screening of a Naïve Antibody Library Using E. coli Display and Single-Step Colony Assay
Mieko Kato, Yoshiro Hanyu
Applied Microbiology (2024) Vol. 4, Iss. 1, pp. 237-249
Open Access

Susceptibility and transmissibility of SARS-CoV-2 variants in transgenic mice expressing the cat angiotensin-converting enzyme 2 (ACE-2) receptor
Nereida Jiménez de Oya, Eva Calvo-Pinilla, Patricia Mingo‐Casas, et al.
One Health (2024) Vol. 18, pp. 100744-100744
Open Access

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity
Ron Geller, Julia Revuelta, Luciana Rusu, et al.
Research Square (Research Square) (2024)
Closed Access

Production of Plant Virus-Derived Hybrid Nanoparticles Decorated with Different Nanobodies
Enrique Lozano‐Sanchez, José‐Antonio Daròs, Fernando Merwaiss
ACS Nano (2024)
Open Access



Bulletin of Russian State Medical University (2023), Iss. 2023(1)
Open Access


Sitnikov Ds, Ilina Iv, Filatov Ma, et al.
Вестник Российского государственного медицинского университета (2023), Iss. 2023(1)
Open Access

Page 1 - Next Page

Scroll to top